TITLE

Rethinking Treatments For the Heart

AUTHOR(S)
Gorman, Christine
PUB. DATE
January 2001
SOURCE
Time International (South Pacific Edition);1/15/2001, Issue 2, p63
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Discusses the development of drugs for the treatment of heart diseases. Use of surgery to treat heart disease; Use of the human genome to develop drugs; How men and women at risk for heart disease will be identified at earlier stages of their condition; How drugs known as statins, can curb the body's ability to manufacture excess cholesterol; Outlook.
ACCESSION #
3980134

 

Related Articles

  • Rethinking Treatments For the Heart. Gorman, Christine // Time;1/15/2001, Vol. 157 Issue 2, p85 

    Discusses the development of drugs for the treatment of heart diseases. Use of surgery to treat heart disease; Use of the human genome to develop drugs; How men and women at risk for heart disease will be identified at earlier stages of their condition; How drugs known as statins, can curb the...

  • Cardiovascular News Round-up.  // PharmaWatch: Monthly Review;Jul2005, Vol. 4 Issue 7, p12 

    The article reports global developments related to the cardiovascular field of the pharmaceutical industry. A study by researchers from Stanford University School of Medicine revealed that doctors are under utilizing statins as treatments for heart disease. The study suggesting bolder use of...

  • Cholesterol study ranks effectiveness of statins. Gough, Rob // Pulse;11/11/2002, Vol. 62 Issue 43, p7 

    Examines the use of statins for first-line treatment of coronary heart disease (CHD) in Great Britain. Efficacy of statins in reducing cholesterol in the body; Mechanism of action of each agent; Benefits of the treatment for CHD patients.

  • Patients with acute coronary syndrome should start a statin while still in hospital. Isles, C.G. // Heart;Jul2002, Vol. 88 Issue 1, p5 

    Editorial. Focuses on the use of statins for the treatment of coronary heart disease in Great Britain. Clinical profile of patients with coronary heart disease; Barriers to prescribing prophylactic drugs following myocardial infarction; Beneficial effects of statins.

  • Use of statins in the secondary prevention of coronary heart disease: is treatment equitable? Reid, F.D.A.; Cook, D.G.; Whincup, P.H. // Heart;Jul2002, Vol. 88 Issue 1, p15 

    Objective: To investigate possible inequities in the use of statins for people with coronary heart disease according to a wide range of social and clinical factors. Design and setting: Cross sectional analysis of data from the Health Survey for England 1998, a population based survey. Subjects:...

  • Studies focus on effects of statins on heart patients.  // Drug Utilization Review;Apr2002, Vol. 18 Issue 4, p31 

    Presents a study which discussed the effects of statins on hospitalized patients with cardiac diseases.

  • `Give statins to the elderly'. Pownall, Mark // GP: General Practitioner;11/25/2002, p4 

    Focuses on the prescription of general practitioners in Great Britain to use statins, cardiovascular agents for heart disease treatment of older people. Efficiency of statins to reduce heart disease related death rates in aged people; Availability of statins to elderly people in Great Britain;...

  • Effects of atorvastatin (and blood pressure lowering comparing amlodipide-based therapy with beta-blocker-based therapy) on serum variables of cholesterol synthesis and absorption, thrombogenicity and on low-density lipoprotein oxidation in vivo. Nieminen, M S; Viikari, J; Ahotupa, M; Vasankari, T; Kantola, I; Strandberg, T; Vanhanen, H // Journal of Human Hypertension;Aug2001 Supplement, Vol. 15 Issue 8, pS27 

    Discusses effects of atorvastatins on the prevention of coronary heart disease complications. Reasons provided for occurrence of the heart diseases in patients despite statin treatment; Effect of atorvastatin on atherogenic lipid profile; Impact of statins on low-density lipoprotein composition.

  • Case history: Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors. Tobert, Jonathan A. // Nature Reviews Drug Discovery;Jul2003, Vol. 2 Issue 7, p517 

    In the 1950s and 1960s, it became apparent that elevated concentrations of plasma cholesterol were a major risk factor for the development of coronary heart disease, which led to the search for drugs that could reduce plasma cholesterol. One possibility was to reduce cholesterol biosynthesis,...

Share

Read the Article

Other Topics